The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Roche; Sanofi
FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial.
 
Marc Ychou
Honoraria - Bayer; Merck; Roche
Consulting or Advisory Role - Bayer; Merck; Roche
 
Michel Rivoire
Honoraria - Roche; Sanofi
Consulting or Advisory Role - Roche; Sanofi
Research Funding - Bayer (Inst); Roche (Inst); Sanofi (Inst)
 
Simon Thezenas
No Relationships to Disclose
 
Rosine Guimbaud
Research Funding - Roche (Inst)
 
Francois Ghiringhelli
No Relationships to Disclose
 
Anne Mercier-Blas
No Relationships to Disclose
 
Laurent Mineur
Honoraria - Amgen; Baxter; Lilly; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxter; Lilly; Roche; Sanofi
Patents, Royalties, Other Intellectual Property - Convergence Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; Baxter; Lilly; Roche; Sanofi
 
Eric Francois
Honoraria - Merck; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Merck; Roche; Sanofi
 
Faiza Khemissa
Honoraria - Roche; Sanofi
 
Driffa Moussata
No Relationships to Disclose
 
Yves Becouarn
No Relationships to Disclose
 
Philippe Houyau
No Relationships to Disclose
 
Thomas Aparicio
Consulting or Advisory Role - Roche
Speakers' Bureau - Roche; Sanofi
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Rene Adam
Honoraria - Amgen; Merck; Sanofi
Consulting or Advisory Role - Amgen; Merck; Sanofi
 
Marie-Pierre Galais
No Relationships to Disclose
 
Franck Audemar
No Relationships to Disclose
 
Eric Assenat
No Relationships to Disclose
 
Trevor Stanbury
No Relationships to Disclose
 
Olivier Bouche
Honoraria - Amgen
Consulting or Advisory Role - Merck Serono; Roche; Teva
Speakers' Bureau - Amgen; Hospira; Lilly; Novartis
Research Funding - Pierre Fabre (Inst)